Literature DB >> 14759426

Clinical outcome after cardiac operations in patients with cirrhosis.

Nobuhiko Hayashida1, Takahiro Shoujima, Hideki Teshima, Yoshinori Yokokura, Kazuyoshi Takagi, Hiroshi Tomoeda, Shigeaki Aoyagi.   

Abstract

BACKGROUND: To evaluate the clinical outcome after cardiac operations in patients with cirrhosis, a retrospective study was undertaken.
METHODS: Between 1989 and 2003, 18 patients with cirrhosis who underwent cardiac operations were identified. Their preoperative status and postoperative clinical results were assessed.
RESULTS: Ten patients were classified as having Child-Pugh class A cirrhosis, 7 as having class B cirrhosis, and 1 as having class C cirrhosis. Fifteen of 18 patients underwent cardiac surgery using cardiopulmonary bypass, and the remaining 3 patients with class B cirrhosis received coronary artery bypass grafting without cardiopulmonary bypass. In patients undergoing cardiopulmonary bypass, 60% of those with class A cirrhosis and 100% of those with class B cirrhosis and class C cirrhosis had postoperative major complications, including infection, respiratory failure, renal failure, bleeding, and gastrointestinal disorder. One of 3 patients (33%) with class B cirrhosis undergoing coronary artery bypass grafting without cardiopulmonary bypass had major complications. The overall postoperative mortality rate was 17%. Hospital mortality of patients with class A cirrhosis, class B cirrhosis, and class C cirrhosis undergoing cardiopulmonary bypass was 0%, 50%, and 100%, respectively. None of 3 patients with class B cirrhosis undergoing coronary artery bypass grafting without cardiopulmonary bypass died in this study.
CONCLUSIONS: Although the incidence of major complications was high, patients with Child-Pugh class A cirrhosis tolerated cardiac surgery satisfactorily. Patients with more advanced cirrhosis, however, may not be suitable for elective cardiac operations with cardiopulmonary bypass. Although our results are not conclusive, coronary artery bypass grafting without cardiopulmonary bypass can be an alternative therapeutic strategy for patients with advanced cirrhosis requiring surgical revascularization.

Entities:  

Mesh:

Year:  2004        PMID: 14759426     DOI: 10.1016/j.athoracsur.2003.06.021

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  23 in total

1.  Stent graft implantation combined with coil embolization and external-internal iliac artery bypass surgery: report of a case.

Authors:  Takeshiro Fujii; Tsukasa Ozawa; Satoshi Hamada; Hiroshi Masuhara; Chikao Teramoto; Masanori Hara; Tomoyuki Katayanagi; Yuki Sasaki; Nobuya Koyama; Yoshinori Watanabe
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

2.  Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery.

Authors:  Chandra Kant Pandey; Sunaina Tejpal Karna; Vijay Kant Pandey; Manish Tandon; Amit Singhal; Vivek Mangla
Journal:  World J Gastrointest Surg       Date:  2012-12-27

3.  Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery.

Authors:  Kazumasa Tsuda; Masaaki Koide; Yoshifumi Kunii; Kazumasa Watanabe; Satoshi Miyairi; Yuko Ohashi; Takashi Harada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-12

4.  Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality.

Authors:  Cheng-Hsin Lin; Ron-Bin Hsu
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Preoperative evaluation using asialoscintigraphy in patients undergoing cardiac surgery with noncardiac liver cirrhosis.

Authors:  Yoshiyuki Takami; Hiroshi Masumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-11

6.  In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.

Authors:  Nadim Mahmud; Zachary Fricker; Marina Serper; David E Kaplan; Kenneth D Rothstein; David S Goldberg
Journal:  Liver Int       Date:  2019-06-17       Impact factor: 5.828

Review 7.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

8.  Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study.

Authors:  Yong An; Ying-Bin Xiao; Qian-Jin Zhong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis.

Authors:  Maarouf-A Hoteit; Amaar-H Ghazale; Andrew-J Bain; Eli-S Rosenberg; Kirk-A Easley; Frank-A Anania; Robin-E Rutherford
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

10.  Preoperative evaluation of patients with liver cirrhosis undergoing open heart surgery.

Authors:  Takashi Murashita; Tatsuhiko Komiya; Nobushige Tamura; Genichi Sakaguchi; Taira Kobayashi; Tomokuni Furukawa; Akihito Matsushita; Gengo Sunagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.